John Park, MD
Anesthesiology · Bristol, PANPI 1205862075
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,023 of the $1,312 with a category attached, or 78.0%. It is spread thinly across 20 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $562 and has fallen 67.5% since, to $182 in 2025. Among anesthesiology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 47 payments — averaging $27.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Curonix LLC$305
- Sun Pharmaceutical Industries Inc.$274
- Nevro Corp.$218
- AbbVie$177
- Collegium Pharmaceutical, Inc.$40
- Daiichi Sankyo Inc.$37
- plus $262 from 14 others
What the payments were for
- Travel & lodging$28922%
- Food & beverage$1,02378%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Curonix LLC | 3 | $305 |
| Sun Pharmaceutical Industries Inc. | 16 | $274 |
| Nevro Corp. | 3 | $218 |
| AbbVie | 4 | $177 |
| Collegium Pharmaceutical, Inc. | 3 | $40 |
| Daiichi Sankyo Inc. | 2 | $37 |
| Harrow Eye, LLC | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Boston Scientific | 1 | $29 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
| Sight Sciences, Inc. | 1 | $22 |
| Apellis Pharmaceuticals, Inc. | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Bausch & Lomb Americas Inc. | 1 | $14 |
| AstraZeneca | 1 | $13 |
| Kaleo, Inc. | 1 | $12 |
| Biodelivery Sciences International, Inc. | 1 | $12 |
| Pernix Therapeutics Holdings, Inc. | 1 | $12 |
| Novartis | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,312 in reported general payments places this provider in the 90th percentile of 2,015 anesthesiology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anesthesiology in Bristol
- Lee FleisherPhiladelphia$659K
- Eugene ViscusiPhiladelphia$398K
- Joseph AnswineMechanicsburg$255K
- Michael ScottPhiladelphia$250K
- William McIvorPittsburgh$226K
- Jonathan WatersPittsburgh$191K
- Nirmal ShahAllentown$85K
- Joshua AtkinsPhiladelphia$55K
- Sanjib AdhikaryHershey$47K
- Patrick FallAbington$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.